Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

Biogen proposed acquiring Sage Therapeutics for $7.22 per ... The company’s layoff impacted over 165 employees (approximately 33% of its total workforce and approximately 55% of its R&D ...

On Friday, Sage Therapeutics Inc. (NASDAQ ... The company’s layoff impacted over 165 employees (approximately 33% of its total workforce and approximately 55% of its R&D workforce), including ...

Tenax Therapeutics focuses ... bringing the total to 8,336,600 shares. This reflects the company's intent to attract, retain, and motivate its employees, officers, and directors.

Tenax Therapeutics focuses on addressing cardiovascular and pulmonary diseases with high unmet medical needs. Besides ...

Biogen has made an unsolicited offer to acquire its partner Sage Therapeutics ... off 165 employees – representing 55% of its research and development staff and 33% of its total workforce ...

Biogen has made an unsolicited offer to acquire its partner Sage Therapeutics following ... This included laying off 165 employees – representing 55% of its research and development staff and 33% of ...

SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $7.1 which represents a slight increase of $0.08 or 1.14% from the prior close of $7.02. The stock opened at $7.02 and touched ...

(RTTNews) - Sage Therapeutics, Inc. (SAGE) Monday announced that its Board of Directors has initiated a strategic review process aimed at maximizing shareholder value, involving a wide range of ...